Endometriosis is a common and potentially debilitating gynecologic disorder that is often undiagnosed or misdiagnosed. With no reliable noninvasive tests for chronic pain due to endometriosis available, other conditions must be ruled out before a diagnosis can be made. Pharmacotherapy based on a woman’s age, symptoms, and preferences plays an important role in the management of endometriosis. This activity addresses the burden of endometriosis, diagnosis, and long-term management—including new and emerging treatments that show promise in alleviating the pain and other symptoms of the disease.
eNewsletter with interactive benchmarking and audio commentary
To educate NPs and PAs on the importance of early detection and diagnosis of endometriosis, pharmacologic treatment approaches, promising new therapies currently under investigation, and the need for a collaborative approach for long-term management.
After completing this activity, participants should be better able to:
- Differentiate the multiple causes of chronic pelvic pain in women to help facilitate the early diagnosis of endometriosis
- Describe appropriate treatment approaches for endometriosis based on patient factors and preferences and the efficacy and safety of available and emerging treatments
- Create patient‐centered strategies for the long‐term management of endometriosis and management of treatment side effects
NPs and PAs
CNE Credit Designation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
Nurse Planner: Melanie Deal, MSN, WHNP-BC, FNP-BC
PA Planner: Nisha McKenzie, PA-C, IF, CSC
AAPA Credit Designation Statement
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until January 31, 2020. PAs should only claim credit commensurate with the extent of their participation.
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from AbbVie Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr As‐Sanie: consultant: AbbVie Inc. and Myovant.
The Planning Committee for this activity included Ruth Cohen and Margaret Reith of Continuing Education Alliance; Melanie Deal, MSN, WHNP-BC, FNP-BC of the University of California, Berkeley and Nisha McKenzie, PA-C, IF, CSC of Grand Rapids OB/GYN. Ms McKenzie reports being a speaker for Amag Pharmaceuticals. The remaining members of the Planning Committee have no relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the activity in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: January 31, 2019
Expiration date: January 31, 2020
© 2020 Practicing Clinicians Exchange. All Rights Reserved. APCE95618